For anyone who wants to understand Melcor Developments' profit beyond the statutory numbers, it's important to ...

Arnab Basu, MD, MPH, FACP, explains why sensitivity might be higher in urothelial cancer vs other genitourinary cancers.

In operable non-small cell lung cancer (NSCLC), molecular residual disease (MRD) detection via circulating tumor DNA (ctDNA) ...

In a real-world study involving patients with standard-risk, newly-diagnosed multiple myeloma (NDMM), there was no significant difference identified in the level of minimal residual disease (MRD) ...

So, MRD, or minimal residual disease, testing is just a more sensitive technique to detect disease that cannot be detected by conventional technologies. There's a couple of ways to do it by our ...

Adaptive Biotechnologies Corp (ADPT) reports a 22% revenue increase, driven by MRD growth, while managing cost reductions and ...

Adaptive Biotechnologies (ADPT) expects full year revenue for the MRD business to be between $143 million and $145 million, updated from the previous range between $140 million and $145 million. No ...

Last week, readers were most interested in a story about Tempus' expectations for its acquisition of cancer testing firm Ambry.

Mount Ridley Mines Limited (AU:MRD) has released an update. Mount Ridley Mines Limited has announced the appointment of Kieran Witt as a director, ...

Getting kids off their screens and into the wild (or even a nearby trail) is the top priority for the state’s Generation Wild ...

Siemens kauft den amerikanischen Softwarespezialisten Altair Engineering, der Programme für Luft- und Raumfahrt sowie die ...